chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The POSSIBLE adverse reactions being reported, on the advice of the pharmacist are: stiffening left arm, stiffening left hand, head throbbing on left side.  [The second vaccine was given on the Monday following my Thursday kidney surgery on March 4, 2021. Since then, have seen health care professionals and had numerous tests performed (e.g., hemoglobin blood test, CMP, EKG 2x, cartoid artery ultrasound). No known or explanable reason or reasons for my dizziness, head throbbing, arm weakness, etc., have been specifically stated, merely speculation on the part of all providers, resulting in experimentation with doses especially of the high blood pressure Rx (Labatol was Rx'd for a time, but discontinued, about 2 weeks ago).  Regardless of the medicines prescribed, the dizziness, head throbbing have continued and the "heaviness" or stiffening in the L arm has increased, perhaps due to my sleep positions as a result of the uncomfortable sleep position tried after my surgery. (A hematoma developed and took a while to resolve, so perhaps, "bad sleep posture" is the casual factor in all of these symptoms???)
Case number PHEH2015US000941 is an initial spontaneous report from a consumer received on 09 Jan 2015. This report refers to a 70-year-old female patient. She was vaccinated with FLUVIRIN (batch number: not reported) intramuscularly in the left upper arm on 18 Oct 2014. On the same date, after vaccination she experienced pain in her left upper arm near injection site. She had no redness and swelling at site. The outcome of the event reported as not recovered. The seriousness and causality of the event were not reported.
Pink circular, upraised rash around site of injection. Denies fever. Diameter was about 3/4 an inch.
Both injections given in same arm. Patient returns 2 days later with prescription for clindamycin, states she has developed cellulitis.
The pt woke with red area on left upper thigh and was hot to the touch, 3cm erythema and induration.
Redness & swelling (Induration) at injection site on (R) thigh - Dtap. Redness @ (L) thigh - prevar Redness.
No additional adverse effect reported; an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was administered 10-AUG-2021.; This spontaneous report has been received from a medical assistant, referring to a patient of unknown age and gender. Information about the patient's concurrent conditions, pertinent medical history, concomitant medications, previous drug and/or allergy reactions were not reported.  On 10-AUG-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) (strength, dose, formulation, vaccination scheme, route and anatomical location of administration were not reported, lot number T003714, has been verified to be valid, expiration date reported and established as 29-JUL-2021) for prophylaxis (expired product administered). No previous temperature excursion and no additional adverse event were reported.
Around 6am on Sunday,  the day after I received the vaccine, I woke up with the following symptoms: injection site pain, fatigue, headache, chills, fever, nausea, swelling in my under arm and loss of taste. I was out for the entire day.  On Monday, I woke up with the same symptoms but they were milder than the day before.  I called to schedule an appointment with my doctor today, Tuesday, to go over my reaction to the vaccine.  I still have swelling under my arm and loss of taste and fatigue.
Began with bleeding in left eye, then fluid build up, macular hole development (unsure), and retinal detachment (@ Feb 2022)
Projectile vomiting at 4:50 am, headache onset overnight became severe, tingling/pins and needles hands all next day, then arm of injection became red, swollen and warm to touch
was down for two days; This case was reported by a consumer via interactive digital media and described the occurrence of feeling down in a 65-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (shingles on back and chest when patient was about 45 years and was out of work for two weeks).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling down. On an unknown date, the outcome of the feeling down was recovered/resolved.   It was unknown if the reporter considered the feeling down to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported the case. The patient was given the shingles vaccine and had a bad reaction to shingles shots where the patient was down for two days. The follow up would not be possible as no contact details were available. For tolerance of 2nd dose refer case US2021AMR195343, reported with same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR195343:Same reporter
Patient stated that injection was administered into the area above the deltoid.  Has been experiencing soreness and weakness since the day of the injection after feeling abnormal pain during the injection. With physical therapy he said that some of the strength has recovered but is still not completely back to normal.
A non-serious spontaneous report of "administration of expired product" and "vaccine given to a patient" was received from a non healthcare professional concerning a 76-year-old male out of 18 patients. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 15-Jan-2010. On 20-Jan-2010, the patient received expired H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
Sick; Sore and red Arm; Sore and red Arm; Nauseous; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Apr-2021 and was forwarded to Moderna on 02-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), ERYTHEMA (Sore and red Arm), PAIN IN EXTREMITY (Sore and red Arm) and NAUSEA (Nauseous) in a 44-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced ILLNESS (Sick), ERYTHEMA (Sore and red Arm), PAIN IN EXTREMITY (Sore and red Arm) and NAUSEA (Nauseous). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency and IBUPROFEN for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, ILLNESS (Sick), ERYTHEMA (Sore and red Arm), PAIN IN EXTREMITY (Sore and red Arm) and NAUSEA (Nauseous) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: updated the outcome of events to Recovered/Resolved
Hospitalized 6/22/22-6/25/22 Fall, dizziness, UTI, hip fx, weakness, cough, fever, chills, SOB,
day1: one hour after injection, cold sensation, numbness in face and hands day7:  Intermittent anxiety, panic attacks, numbness in face and hands.  Intermittent headache, "ice blood" feeling, feeling weighted down, chronic fatigue, insomia.  Lasting a few days day13-25:  Intermittent anxiety, panic attacks, numbness in face and hands.  Intermittent headache, "ice blood" feeling, feeling weighted down, chronic fatigue, insomnia, vertigo.  Symptoms worse after meals.  Clear up for a few days, then return.  Descriptions of "long  covid" match these symptoms.  Inability to engage in any physical activity when symptomatic.
Patient received PREVNAR vaccine on 8/12/11 (L) thigh. Went to ER on 8/14/11 with cellulitis (L) thigh. Was given ROCEPHIN injection for antibiotics and it did clear up. On 10/12/11 received PREVENAR injection in (R) leg. Same reaction. Was put on AUGMENTIN antibiotics and it did clear up. 3cm x 4cm red, hard, swollen area.
swelling rt deltoid, c/o small rt finger being numb & tingling, c/o lightheadedness & dizziness;no DPH given
This spontaneous report was received from a registered nurse and refers to a 4 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 06-JUL-2017, the patient was vaccinated with an improperly stored PROQUAD at a dose of 0.5 (units not specified), lot # N002336 with expiry date 19-JUL-2018 (dose number, route and anatomical location not reported) for prophylaxis. Concomitant therapies included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1707USA006208:
feeling very sick; FEVERISH; HEADACHE; BODY ACHE; JOINT PAIN; NAUSEOUS; feeling blue and black; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (feeling very sick), PYREXIA (FEVERISH), HEADACHE (HEADACHE), MYALGIA (BODY ACHE) and ARTHRALGIA (JOINT PAIN) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pacemaker insertion (cardiac). Concurrent medical conditions included Hypertension, Diabetes mellitus and Cholesterol.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ILLNESS (feeling very sick), PYREXIA (FEVERISH), HEADACHE (HEADACHE), MYALGIA (BODY ACHE), ARTHRALGIA (JOINT PAIN), NAUSEA (NAUSEOUS) and FEELING ABNORMAL (feeling blue and black). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, ILLNESS (feeling very sick), PYREXIA (FEVERISH), HEADACHE (HEADACHE), MYALGIA (BODY ACHE), ARTHRALGIA (JOINT PAIN), NAUSEA (NAUSEOUS) and FEELING ABNORMAL (feeling blue and black) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were taking medications for HTN, Diabetes, Cholesterol .
This report was received from GSK for Infanrix and was assigned manufacturer report number A0408220A. This was originally reported by a health professional concerning a 5 year old male pt who on 15MAY2003 was vaccinated with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live (second generation). Concomitant therapy on 15MAY2003 included a fifth dose of diphtheria toxoid/pertussis vaccine/teta (INFANRIX) and a dose of poliovirus vaccine. The pt's medical history, concurrent conditions and concurrent medications were not reported. On 15MAY2003 2-3 hours post vaccination the pt developed hives on the ears and face. The parents telephoned the physician and were instructed to administer diphenhydramine hydrochloride and to keep the area cool. The reporter considered the hives to probably be related to the Infanrix administration. It was unknown if the patient recovered. Additional information has been requested.
Pain in upper left arm where I was vaccinated. As the days went on pain was steady and would sometimes travel down the arm.  Pain when I tried to lift arm over my head or in back.  Broken sleep. I now have very bad pain and stiffness upon waking up in morning.  Finally decided I need to have it checked out by physician.  Just a note, I was sitting and the pharmacist was standing when he injected vaccine.  I am now on prednisone for a few days and prescribed topical creme. Just another note, after this experience I will never have another flu shot.  Had my first flu shot last year with no problems.
Our son's doctor recently prescribed Acthar to treat his opsyclonus. This prescription was denied coverage on 05/02/2022 by your company because of necessity. We are writing this letter to appeal that decision.   We are asking that you cover Acthar because it is very important to the health and happiness of our 3 month old baby. Pt. is struggling to focus, follow and see well because of a serious reaction to his 2 month vaccines. Our once happy, alert, focused and aware child now struggles to see and watch his mobile or focus on our faces. We have struggled through weeks of doctor's appointments where he has been poked, prodded and examined through several scans, blood tests, urine tests and injections to determine the correct path for treatment. After weeks of being in and out of hospitals and private care doctor's we have come to the correct game plan to get out little man back on track. Acthar has been described to us as being 80-90% effective for our son's condition, compared to other treatments that only muster 30-40% effective according to his doctor's research. This could mean the difference between our baby having a normal, healthy life and struggling for the foreseeable future with this impairment which could cause cognitive issues. We implore you to please reconsider approving our baby for Acthar therapy so we can begin to get him the help he needs to correct his vision before any more precious time is lost.  Pt. has been prescribed other medications to treat his condition, but they have not worked for him. We currently have pt. on prednisolone which has made little improvement to his current neurological issues. He still has wild eyes (opsyclonus) and is not able to focus.
trembling; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (trembling), NAUSEA (nausea) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced TREMOR (trembling), NAUSEA (nausea) and HEADACHE (headache). On 02-Mar-2021, TREMOR (trembling), NAUSEA (nausea) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: abnormal (abnormal) sudden increase and decrease in temperature.         No concomitant medication was mentioned. No treatment medication was mentioned.  The patient had experienced no adverse event after receiving the first dose of the vaccine.
This spontaneous report was received from a healthcare worker and refers to a 12 week old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 06-JUL-2015 and on 10-SEP-2015, the patient was vaccinated with two separate doses of improperly stored oral, ROTATEQ (doses were not provided) lot # K015816, expiration date: 29-MAR-20016 and lot # K016261, expiration date: 23-JUN-2016, orally. No adverse effects were reported. Additional information has been requested.
Red itchy rash on neck and chest for one week and then reoccurring 3 times. 3rd time rash is on neck and chest as well as right arm.
Pt. had swollen red area on (L) arm at Varicella vaccine injection site, starting PM on 10/14/08. Area still swollen, warm to touch, red, tender on 10/15/08. BENADRYL prescribed. Redness/edema, 6cm x 7cm in size.
VERY MILD CASE; This spontaneous report received from a patient via a social media and company representative concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: Unknown and expiry: Unknown ) dose ,start therapy date were not reported, dose number in series 1, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced very mild case (dose number in series was 1). It was reported that "Son currently has it, got J&J vax, very mild case". On an unspecified date, the patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: Unknown and expiry: Unknown ) dose ,start therapy date were not reported, dose number in series 2, 1 total administered for prophylactic vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from very mild case. This report was non-serious. This report was associated with product quality complaint number: 90000209146. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed a manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. This case, from the same reporter is linked to 20211261126 and 20211261154.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case is assessed as non serious
3/5- fever T 100.7, vomiting x 2. + intermittent bilateral knee pain in popliteal fossa. 3/9 AM pt refused to walk due to pain, Tylenol used. Pt is OK in PM. No further pain since 3/14/15.
ill with gas; can't walk; can't move arms; Initial information received on 14-Dec-2020 regarding an unsolicited valid serious case received from a consumer or non-healthcare professional via media.  This case involves a 69-years-old male patient who experienced ill with gas (flatulence), can't walk (gait inability) and can't move arms (limb immobilisation), while he received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) lot number not reported via an unknown route at an unknown administration site for professional.  On an unknown date, the patient was ill with gas (flatulence), can't walk (gait inability) and can't move arms (limb immobilisation) (unknown latency) following the administration of INFLUENZA VACCINE. The patient was hospitalized these events for duration of three months, rest home over a month.  It is unknown if the patient experienced any additional symptoms/events.  Medication details and reason for taking the medicine was unknown.  Patient's wife took the low dose while husband got the double dose of the INFLUENZA VACCINE.  There were no lab data/results available.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown for gait inability and limb immobilisation.  At the time of this report, outcome of the flatulence was not recovered (going on since 5-months).  Batch number has been requested for suspect product for this case.; Sender's Comments: This poorly documented media case concerns a 69-years-old male who suffered from flatulence, gait inability and limb immobilisation after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset was unknown. However, patient's medical condition at the time of vaccination, lab tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.
I received my first dose on 12/23/20. 2 weeks after my first dose I had a mild rash on my back with a discolored appearance to it. It went away. I did not think it was from the vaccine because it had been two weeks from the time I had it. I received my second vaccine on 1/22/21. I now have the exact same rash back but much darker and it itches quite a bit more. I decided to have it checked. I went to emergency room/urgent care. The NP stated she felt it was vaccine related and gave me a prescription for Steroids. She told me to let her know if it got worse or did not go away. I attached an image of the rash I obtained after the second dose.
Patient came back to clinic to get PPD. Read 48 hours after vaccine given and nurse noticed hard and warm LUA and erythema.
They had a mild case of Covid in Apr2023; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (They had a mild case of Covid in Apr2023) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for an unknown indication.    Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (Dose 1) and Moderna COVID-19 Vaccine (Dose 2); for Product used for unknown indication: JANSSEN COVID-19 VACCINE (Dose 2, Batch Number unknown), JANSSEN COVID-19 VACCINE (Dose 1 and Batch Number unknown). Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE, JANSSEN COVID-19 VACCINE, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine.   In September 2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. In April 2023, the patient experienced COVID-19 (They had a mild case of Covid in Apr2023). At the time of the report, COVID-19 (They had a mild case of Covid in Apr2023) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication not reported. Treatment medication not reported.   Reporter did not allow further contact
Patient has inflammation around injection site. It feels hot, swollen, and burns in the area. She also complains of diarrhea.
2 large blisters on lt arm where varicella vaccine was placed. Pt also has erythema/induration of 4cm x 5cm surrounding area where varicella vaccine placed. Pt has erythema/induration also on the rt arm of 3cm x 3cm. Dtap and MMR were placed on this side.
Fever, Headaches, Shivers, Nausea, Fatigue. Fever started 8 hours after I received the vaccine and excruciating headaches followed. The night after I received the vaccine, I had long shivers and cold sweat. The next day, headaches continued alongside nausea and fatigue.